Article Detail - JF Part A
MolDX: Melanoma Risk Stratification Molecular Testing - Effective December 06, 2020
This Local Coverage Determination (LCD) has completed the Open Public Meeting and comment period and is now finalized under contractor numbers: 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY). Responses to comments received may be found as a link at the bottom of the final LCD.
Medicare Coverage Database (MCD) Number/Contractor Determination Number: L37748
LCD Title: MolDX: Melanoma Risk Stratification Molecular Testing
FORMERLY: MolDX: DecisionDx-Melanoma
Effective Date: December 06, 2020
Summary of LCD: Molecular diagnostic tests used to assist in risk stratification of melanoma patients.
Visit the Future LCDs webpage to access this LCD.
Last Updated Thu, 22 Oct 2020 17:33:43 +0000